Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
IU Ventures
AddedFeb 15, 2024
UpdatedJun 28, 2026
IU Ventures

IU Ventures

Operating

Driving global social and economic impact through strategic investments.

Location
Bloomington, IN, US
Founded
1997
Firm
Compare
Portfolio
Employees
Website

Investments

Plan Forward
Plan Forward

Total Raised

$2.3M

Rounds

3

Seed$2MOctober 2023
Confluence Pharmaceuticals
Confluence Pharmaceuticals

Total Raised

$2M

Rounds

5

Series Unknown$200kJune 2022
Convertible Note$100kDecember 2020
Folia
Folia

Total Raised

$2M

Rounds

1

Seed$2MMay 2022
The Bee
The Bee

Total Raised

$4.2M

Rounds

9

Series Unknown$1.1MFebruary 2022
HotDrop
HotDrop
Pre-Seed

Total Raised

$20k

Rounds

3

Pre-SeedJanuary 2022
Kovina Therapeutics
Kovina Therapeutics

Total Raised

$2.6M

Rounds

4

Seed$2MOctober 2021
NuCurrent
NuCurrent

Total Raised

$16.1M

Rounds

7

Series Unknown$375kAugust 2021
Series C$1MSeptember 2019
Apexian Pharmaceuticals
Apexian Pharmaceuticals

Total Raised

$6.9M

Rounds

8

Series Unknown$100kAugust 2021
Amplified Sciences
Amplified Sciences

Total Raised

$4.7M

Rounds

5

Seed$1.8MAugust 2021
Mentor Collective
Mentor Collective

Total Raised

$28.5M

Rounds

7

Debt$500kMay 2021
Seed$3.2MSeptember 2019
Encamp
Encamp

Total Raised

$47.2M

Rounds

6

Series B$12MApril 2021
Series A$3.1MMay 2020
Diagnotes
Diagnotes

Total Raised

$2.6M

Rounds

5

Series UnknownOctober 2020
Qumulex
Qumulex

Total Raised

$2.8M

Rounds

1

Seed$2.8MSeptember 2019
Nerx Biosciences
Nerx Biosciences

Total Raised

$500k

Rounds

1

Seed$500kJune 2019
Openinsights
Openinsights

Total Raised

$1.9M

Rounds

3

Angel$1.2MMarch 2019
Pre-Seed$400kDecember 2018
Allinaire Therapeutics
Allinaire Therapeutics

Total Raised

$1.6M

Rounds

1

Seed$1.6MJanuary 2017
PrecisionHawk
PrecisionHawk

Total Raised

$136M

Rounds

7

Series C$18MApril 2016
DinnerCal
DinnerCal

Total Raised

$400k

Rounds

1

Series Unknown$400kJuly 2015
MatterFab
MatterFab

Total Raised

$13.2M

Rounds

3

Series A$5.8MMay 2015
Haven
Haven

Total Raised

$1M

Rounds

1

Seed$1MOctober 2014